Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.55 USD | -1.44% |
|
+4.28% | +10.54% |
07-01 | Raymond James Initiates AxoGen at Outperform With $13 Price Target | MT |
06-24 | Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.54% | 335M | |
+1.58% | 204B | |
+3.61% | 178B | |
+31.67% | 154B | |
+32.31% | 112B | |
+1.71% | 64.32B | |
+21.17% | 54.88B | |
-1.61% | 47.24B | |
-9.14% | 36.8B | |
-0.19% | 35.26B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- AxoGen, Inc. Appoints Ivica Ducic as Medical Director of Clinical and Translational Sciences